BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2025 8:37:59 AM | Browse: 177 | Download: 90
 |
Received |
|
2025-03-21 09:54 |
|
Peer-Review Started |
|
2025-03-21 09:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-08 12:54 |
|
Revised |
|
2025-04-15 04:11 |
|
Second Decision |
|
2025-07-30 02:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-07-30 07:11 |
|
Articles in Press |
|
2025-07-30 07:11 |
|
Publication Fee Transferred |
|
2025-04-23 02:02 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-21 06:53 |
|
Publish the Manuscript Online |
|
2025-09-15 08:37 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Retrospective Study |
| Article Title |
Comparative impact of antiviral therapies on postoperative recurrence risk in patients with hepatitis B virus-related hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hua-Mei Liu, Xin Zhang, Hang-Ying Huang, Jia-Min Sun and Qing-Dong Tong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Qing-Dong Tong, Chief Physician, MD, Department of Infectious Diseases, The Second Hospital of Longyan, No. 153 Dongxing Road, Xinluo District, Longyan 364000, Fujian Province, China. 13616906527@163.com |
| Key Words |
Hepatitis B virus; Hepatectomy; Hepatocellular carcinoma; Tenofovir disoproxil fumarate; Entecavir; Relapse |
| Core Tip |
This study compared the recurrence rate of hepatocellular carcinoma (HCC) after radical resection of HCC in patients treated with entecavir (ETV) or tenofovir fumarate (TDF) after propensity score matching. Results revealed that HCC recurrence was observed in 33 (66.0%) patients in the ETV group and 21 (42.0%) in the TDF group, and the risk for HCC recurrence was lower in the TDF group than in the ETV group (P = 0.016). The cumulative recurrence rates of HCC at 1, 3, and 5 years in the ETV and TDF groups were 26.0%, 58.0%, and 66.0%, and 18.0%, 38.0%, and 42.0%, respectively (P = 0.045). |
| Publish Date |
2025-09-15 08:37 |
| Citation |
<p>Liu HM, Zhang X, Huang HY, Sun JM, Tong QD. Comparative impact of antiviral therapies on postoperative recurrence risk in patients with hepatitis B virus-related hepatocellular carcinoma. <i>World J Gastrointest Oncol</i> 2025; 17(9): 106297</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i9/106297.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i9.106297 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
